Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)Blue Cross Blue Shield Kansas Diabetes PA | OpenPa…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - KansasPolicy N/A

    Diabetic Testing Supplies Prior Authorization with Benefit Limit Criteria — Medicare Part B

    Customize your policy alerts

    Sign up for all blue cross blue shield - kansas policy alerts

    Know when blue cross blue shield - kansas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This Medicare Part B program governs prior authorization and benefit limits for diabetic testing supplies, including blood glucose test strips, test cartridges, lancets, and associated meters or devices, for eligible members in Alabama, Kansas, Mississippi, and Nebraska.

    Policy Summary
    PayerBlue Cross Blue Shield - Kansas
    PolicyDiabetic Testing Supplies Prior Authorization with Benefit Limit Criteria — Medicare Part B
    Policy CodePolicy N/A
    Change TypeAnnual reviewcriteria maintained
    Effective DateN/A
    Next Review DateN/A
    Key ActionFor a nonpreferred product, document failure of or limitations precluding use of all preferred diabetic testing supply products.
    SourceLink
    POLICY UPDATE CHANGES

    The criteria were reviewed in February 2025 and maintained.

    204/30 daysBenefit limit
    90 daysQualifying look-back
    NonpreferredPrior authorization
    AllQuantity limits

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3Limited supply categories

    Coverage Criteria

    Prior Authorization Approval Criteria

    Diabetic testing supply targets will be approved when ALL of the following are met:

    Approval requirements

    • Qualifying indication

      • Recent diabetes medication: Information has been provided that the patient has been treated with a diabetes medication within the past 90 days.Within the past 90 days
      • Recent concomitant medication: Information has been provided that the patient has been treated with a concomitant drug that may affect blood sugar levels within the past 90 days.Within the past 90 days
      • Gestational diabetes: The patient has gestational diabetes.
      • Prediabetes or diabetes: The patient is prediabetic or diabetic.
    • Preferred-product failure or limitation: The prescriber has provided information indicating that the patient has failed or has limitations precluding use of all preferred diabetic testing supply products.All preferred products

      Required when a nonpreferred product is requested.

    • Quantity requirement

      • Within benefit limit: The requested quantity does not exceed the program benefit limit.204 per 30 days for test strips, test cartridges, and lancets
      • Above-limit request

        • Quantity exceeds limit: The requested quantity is greater than the program benefit limit.Greater than 204 per 30 days
        • Higher-quantity support: The prescriber has provided information in support of therapy with a higher amount for the requested indication.

    Continuous blood glucose monitors are not included in this program. Coverage under this program is limited to the specified diabetic testing supplies and associated products.

    Target Agents and Product Codes

    Benefit Limit Target AgentsHCPCS
    94100030006100Blood Glucose Test Strips; GPI
    M, N, O, or YBlood Glucose Test Strips; multisource code
    94100030006020Test cartridges; GPI
    M, N, O, or YTest cartridges; multisource code
    97202025006300Lancets; GPI
    M, N, O, or YLancets; multisource code
    Alabama/Mississippi-Patrius, Braven, Horizon and North Carolina Preferred Diabetic Testing Supply GPIsHCPCSCovered
    94100030006100OneTouch Ultra/Verio Test Strips; GPI
    97202010006200Contour Blood Glucose Monitoring System; GPI
    97202010006400Contour Next One Blood Glucose Monitoring System; GPI
    97202010006410OneTouch Ultra/Verio Blood Glucose Monitoring Systems and Contour/Contour Next Blood Glucose Monitoring Systems; GPI
    97202025006300OneTouch Lancets, Fingerstix Lancets, Single-Let Lancets, and Microlet Lancets; GPI
    97202027006300OneTouch Delica Plus Lancet and Device Microlet Next Lancet Device; GPI
    M, N, O, or YApplicable multisource code for listed preferred products
    Alabama/Mississippi-Patrius, Braven, Horizon and North Carolina Nonpreferred Diabetic Testing Supply GPIsHCPCS
    94100030006100Blood Glucose Test Strips; GPI
    97202010006200Blood Glucose Monitoring Device; GPI
    97202010006400Blood Glucose Monitoring Kit; GPI
    97202010006410Blood Glucose Monitoring Kit; GPI
    97202025006300Lancets; GPI
    97202027006300Lancet Devices; GPI
    97202030******Lancet Miscellaneous; GPI
    94100030006020Test cartridges; GPI
    M, N, O, or YApplicable multisource code for listed nonpreferred products
    Kansas and Nebraska Preferred Diabetic Testing Supply GPIsHCPCSCovered
    94100030006100Contour/Contour Next Test Strips; GPI
    97202010006200Contour Blood Glucose Monitoring System; GPI
    97202010006400Contour Next One Blood Glucose Monitoring System; GPI
    97202010006410Contour/Contour Next Blood Glucose Monitoring Systems; GPI
    97202025006300Fingerstix Lancets, Single-Let Lancets, and Microlet Lancets; GPI
    97202027006300Microlet Next Lancet Device; GPI
    M, N, O, or YApplicable multisource code for listed preferred products
    Kansas and Nebraska Nonpreferred Diabetic Testing Supply GPIsHCPCS
    94100030006100Blood Glucose Test Strips; GPI
    97202010006200Blood Glucose Monitoring Device; GPI
    97202010006400Blood Glucose Monitoring Kit; GPI
    97202010006410Blood Glucose Monitoring Kit; GPI
    97202025006300Lancets; GPI
    97202027006300Lancet Devices; GPI
    97202030******Lancet Miscellaneous; GPI
    94100030006020Test cartridges; GPI
    M, N, O, or YApplicable multisource code for listed nonpreferred products
    Blood glucose test strips
    SupplyBlood glucose test strips
    Benefit limit204 per 30 days
    GPI94100030006100
    Test cartridges
    SupplyTest cartridges
    Benefit limit204 per 30 days
    GPI

    Prior Authorization and Approval Requirements

    Prior Authorization

    Prior Authorization for Nonpreferred Products

    Prior authorization applies to nonpreferred diabetic testing supply products. The prescriber must provide qualifying documentation for the requested product. Quantity limits apply to all products, including preferred and nonpreferred products.

    • Nonpreferred products require prior authorization.
    • Quantity limits apply to preferred and nonpreferred products.
    Step Therapy

    Preferred-Product Trial or Contraindication

    The prescriber must provide information showing that the patient has failed or has limitations precluding use of all preferred diabetic testing supply products before a nonpreferred product can be approved.

    • Document failure of or limitations precluding use of all preferred products.
    • Preferred test strips include Ascensia/Bayer/Contour in Kansas/Nebraska and Ascensia/Bayer/Contour/OneTouch in Alabama/Mississippi-Patrius, as applicable.

    Clinical Background

    Blood glucose test strips, lancets, and associated meters are used to quantitatively measure glucose and support self-monitoring of blood glucose. These supplies may be used by people with diabetes at home and by healthcare professionals in clinical settings.

    Key Definitions

    Diabetic testing supplies
    Included suppliesBlood glucose test strips, lancets, and associated meters
    MeasurementUsed outside the body to quantitatively measure glucose in blood samples
    UseSelf-monitoring or clinical monitoring of blood glucose
    Preferred products
    DefinitionProducts selected by the plan as preferred diabetic testing supply options
    Market scopeApplicable market
    Examples of market designationKansas/Nebraska and Alabama/Mississippi-Patrius, Braven market preferences are identified separately

    Medical Necessity Determination

    Diabetic Testing Supply Medical Necessity

    Diabetic testing supplies are approved when all applicable prior authorization criteria are met:

    Medical necessity and authorization: The patient has a qualifying diabetes-related indication; when a nonpreferred product is requested, the prescriber has documented failure of or limitations precluding use of all preferred diabetic testing supply products; and the requested quantity is within the benefit limit or is supported above the limit.204 per 30 days for test strips, test cartridges, and lancets unless a higher quantity is supported

    Required Documentation

    Documentation Required

    Provide complete clinical and quantity documentation

    Submit documentation addressing the qualifying clinical indication, failure of or limitations precluding use of all preferred products when a nonpreferred product is requested, and support for any quantity above the benefit limit.

    Excluded Products

    Continuous blood glucose monitors are not covered under this program.

    Policy Summary
    PayerBlue Cross Blue Shield - Kansas
    PolicyDiabetic Testing Supplies Prior Authorization with Benefit Limit Criteria — Medicare Part B
    Policy CodePolicy N/A
    Change TypeAnnual reviewcriteria maintained
    Effective DateN/A
    Next Review DateN/A
    Key ActionFor a nonpreferred product, document failure of or limitations precluding use of all preferred diabetic testing supply products.
    SourceLink
    On This Page
    Coverage CriteriaTarget Agents and Product CodesPrior Authorization and Approval RequirementsClinical BackgroundKey DefinitionsMedical Necessity DeterminationRequired DocumentationExcluded Products
    94100030006020
    Lancets
    SupplyLancets
    Benefit limit204 per 30 days
    GPI97202025006300
    Recent qualifying medication treatment
    Qualifying treatmentTreatment with a diabetes medication
    Look-back periodWithin the past 90 days
    Additional qualifying treatmentTreatment with a concomitant drug that may affect blood sugar levels within the past 90 days
    Documentation Required

    Qualifying Clinical Indication

    Document at least one qualifying diabetes-related indication. The patient must have received treatment with a diabetes medication or a concomitant drug that may affect blood sugar levels within the past 90 days, or have gestational diabetes, prediabetes, or diabetes.

    • Diabetes medication treatment within the past 90 days.
    • Concomitant drug that may affect blood sugar levels within the past 90 days.
    • Gestational diabetes, prediabetes, or diabetes.
    Documentation Required

    Preferred-Product Failure or Limitation

    Provide information indicating that the patient has failed or has limitations precluding use of all preferred diabetic testing supply products.

    • The documentation must address all applicable preferred products, not merely one preferred product.
    Documentation Required

    Higher-Quantity Justification

    For quantities above the program benefit limit, the prescriber must provide information supporting therapy with the higher amount for the requested indication.

    • The requested quantity must exceed the benefit limit.
    • Prescriber support for the higher quantity is required.
    Denial Risk

    No Qualifying Diabetes-Related Indication

    Approval may be denied when no qualifying diabetes-related clinical indication is documented.

    • Document diabetes medication or an affected concomitant drug treatment within the past 90 days, gestational diabetes, prediabetes, or diabetes.
    Denial Risk

    Preferred Products Not Failed or Unsuitable

    Approval may be denied when the prescriber does not document failure of or limitations precluding use of all preferred products.

    • Documentation must support the inability to use every applicable preferred diabetic testing supply product.
    Billing Rule

    Quantity Exceeds Benefit Limit

    Requests above the program benefit limit require prescriber information supporting the higher quantity for the requested indication. The benefit limit is 204 units per 30 days for blood glucose test strips, test cartridges, and lancets.

    • Blood glucose test strips: 204 per 30 days.
    • Test cartridges: 204 per 30 days.
    • Lancets: 204 per 30 days.
    Nonpreferred products
    DefinitionDiabetic testing supply products not designated preferred
    Authorization requirementPrior authorization is required
    Program applicationPrior authorization applies to nonpreferred products only
    Target agents
    Included target suppliesAll diabetic testing supplies
    Program scopeTargeted diabetic testing supplies under this program
    Excluded productContinuous blood glucose monitors are not included